Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2147 | 5031 | 33.5 | 62% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
142 | 3 | DNA REPAIR//INTERNATIONAL JOURNAL OF RADIATION BIOLOGY//RADIATION RESEARCH | 64602 |
2147 | 2 | MGMT//O 6 METHYLGUANINE DNA METHYLTRANSFERASE//O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE | 5031 |
1097 | 1 | MGMT//O 6 METHYLGUANINE DNA METHYLTRANSFERASE//O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE | 2856 |
13533 | 1 | TRIAZENE//BIS TRIAZENE//TRIAZENIDE COMPLEXES | 830 |
16078 | 1 | S 2250 KAWAGISHI//TAUROMUSTINE//SARCNU | 674 |
21701 | 1 | DIPARTIMENTO FARMACOCHIM TOSSICOL BIOL//MTIC//SEZ CHIM FARMACEUT BIOL | 409 |
26128 | 1 | CLORETAZINE//VNP40101M//NEW ANTICANCER AGENT | 262 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | MGMT | authKW | 544645 | 5% | 38% | 239 |
2 | O 6 METHYLGUANINE DNA METHYLTRANSFERASE | authKW | 470629 | 3% | 58% | 133 |
3 | O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE | authKW | 447303 | 2% | 87% | 85 |
4 | TRIAZENE | authKW | 352527 | 2% | 52% | 111 |
5 | ALKYLTRANSFERASE | authKW | 305896 | 1% | 92% | 55 |
6 | O 6 BENZYLGUANINE | authKW | 298995 | 1% | 79% | 62 |
7 | O 6 METHYLGUANINE | authKW | 256905 | 1% | 63% | 67 |
8 | TEMOZOLOMIDE | authKW | 137057 | 4% | 12% | 194 |
9 | CANC UK CARCINOGENESIS GRP | address | 127503 | 1% | 62% | 34 |
10 | BIS TRIAZENE | authKW | 109216 | 0% | 100% | 18 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 22376 | 35% | 0% | 1771 |
2 | Toxicology | 4712 | 10% | 0% | 493 |
3 | Chemistry, Medicinal | 2118 | 7% | 0% | 341 |
4 | Genetics & Heredity | 1863 | 9% | 0% | 468 |
5 | Pharmacology & Pharmacy | 1189 | 11% | 0% | 575 |
6 | Chemistry, Organic | 963 | 8% | 0% | 395 |
7 | Biochemistry & Molecular Biology | 932 | 16% | 0% | 786 |
8 | Chemistry, Multidisciplinary | 616 | 10% | 0% | 512 |
9 | Chemistry, Inorganic & Nuclear | 571 | 5% | 0% | 244 |
10 | Crystallography | 244 | 3% | 0% | 128 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC UK CARCINOGENESIS GRP | 127503 | 1% | 62% | 34 |
2 | DIPARTIMENTO FARMACOCHIM TOSSICOL BIOL | 37710 | 1% | 22% | 28 |
3 | S 2250 KAWAGISHI | 30338 | 0% | 100% | 5 |
4 | PL TOXICOL | 28051 | 1% | 18% | 26 |
5 | SECT GENOME DAMAGE REPAIR | 27697 | 0% | 35% | 13 |
6 | BEIJING ENVIRONM VIRAL ONCOL | 26369 | 0% | 43% | 10 |
7 | SEZ CHIM FARMACEUT BIOL | 24564 | 0% | 45% | 9 |
8 | MED BIOREGULAT BIOCHEM | 24270 | 0% | 100% | 4 |
9 | PATERSON CANC | 20339 | 1% | 6% | 60 |
10 | MOL CELL BIOL CHEM CARCINOGENESIS | 18203 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CARCINOGENESIS | 50352 | 6% | 3% | 311 |
2 | MUTATION RESEARCH | 24270 | 4% | 2% | 181 |
3 | CANCER RESEARCH | 11936 | 6% | 1% | 281 |
4 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 9839 | 2% | 2% | 110 |
5 | ANTI-CANCER DRUG DESIGN | 6000 | 0% | 4% | 25 |
6 | MUTATION RESEARCH-DNA REPAIR | 4461 | 0% | 4% | 19 |
7 | DNA REPAIR | 4018 | 1% | 2% | 37 |
8 | CHEMICAL RESEARCH IN TOXICOLOGY | 2605 | 1% | 1% | 48 |
9 | CLINICAL CANCER RESEARCH | 2483 | 2% | 1% | 80 |
10 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 2131 | 1% | 1% | 26 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MGMT | 544645 | 5% | 38% | 239 | Search MGMT | Search MGMT |
2 | O 6 METHYLGUANINE DNA METHYLTRANSFERASE | 470629 | 3% | 58% | 133 | Search O+6+METHYLGUANINE+DNA+METHYLTRANSFERASE | Search O+6+METHYLGUANINE+DNA+METHYLTRANSFERASE |
3 | O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE | 447303 | 2% | 87% | 85 | Search O+6+ALKYLGUANINE+DNA+ALKYLTRANSFERASE | Search O+6+ALKYLGUANINE+DNA+ALKYLTRANSFERASE |
4 | TRIAZENE | 352527 | 2% | 52% | 111 | Search TRIAZENE | Search TRIAZENE |
5 | ALKYLTRANSFERASE | 305896 | 1% | 92% | 55 | Search ALKYLTRANSFERASE | Search ALKYLTRANSFERASE |
6 | O 6 BENZYLGUANINE | 298995 | 1% | 79% | 62 | Search O+6+BENZYLGUANINE | Search O+6+BENZYLGUANINE |
7 | O 6 METHYLGUANINE | 256905 | 1% | 63% | 67 | Search O+6+METHYLGUANINE | Search O+6+METHYLGUANINE |
8 | TEMOZOLOMIDE | 137057 | 4% | 12% | 194 | Search TEMOZOLOMIDE | Search TEMOZOLOMIDE |
9 | BIS TRIAZENE | 109216 | 0% | 100% | 18 | Search BIS+TRIAZENE | Search BIS+TRIAZENE |
10 | O 6 ALKYLGUANINE | 91368 | 0% | 94% | 16 | Search O+6+ALKYLGUANINE | Search O+6+ALKYLGUANINE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PEGG, AE , DOLAN, ME , MOSCHEL, RC , (1995) STRUCTURE, FUNCTION, AND INHIBITION OF O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE.PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 51. VOL. 51. ISSUE . P. 167 -223 | 219 | 89% | 355 |
2 | PEGG, AE , (2011) MULTIFACETED ROLES OF ALKYLTRANSFERASE AND RELATED PROTEINS IN DNA REPAIR, DNA DAMAGE, RESISTANCE TO CHEMOTHERAPY, AND RESEARCH TOOLS.CHEMICAL RESEARCH IN TOXICOLOGY. VOL. 24. ISSUE 5. P. 618-639 | 184 | 74% | 66 |
3 | GNEWUCH, CT , SOSNOVSKY, G , (1997) A CRITICAL APPRAISAL OF THE EVOLUTION OF N-NITROSOUREAS AS ANTICANCER DRUGS.CHEMICAL REVIEWS. VOL. 97. ISSUE 3. P. 829-1013 | 290 | 68% | 122 |
4 | PEGG, AE , (1990) MAMMALIAN O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE - REGULATION AND IMPORTANCE IN RESPONSE TO ALKYLATING CARCINOGENIC AND THERAPEUTIC AGENTS.CANCER RESEARCH. VOL. 50. ISSUE 19. P. 6119-6129 | 150 | 93% | 754 |
5 | KAINA, B , MARGISON, GP , CHRISTMANN, M , (2010) TARGETING O (6)-METHYLGUANINE-DNA METHYLTRANSFERASE WITH SPECIFIC INHIBITORS AS A STRATEGY IN CANCER THERAPY.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 67. ISSUE 21. P. 3663 -3681 | 115 | 86% | 47 |
6 | CHRISTMANN, M , VERBEEK, B , ROOS, WP , KAINA, B , (2011) O-6-METHYLGUANINE-DNA METHYLTRANSFERASE (MGMT) IN NORMAL TISSUES AND TUMORS: ENZYME ACTIVITY, PROMOTER METHYLATION AND IMMUNOHISTOCHEMISTRY.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1816. ISSUE 2. P. 179-190 | 122 | 73% | 59 |
7 | PEGG, AE , (2000) REPAIR OF O-6-ALKYLGUANINE BY ALKYLTRANSFERASES.MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH. VOL. 462. ISSUE 2-3. P. 83 -100 | 116 | 86% | 374 |
8 | GERSON, SL , (2004) MGMT: ITS ROLE IN CANCER AETIOLOGY AND CANCER THERAPEUTICS.NATURE REVIEWS CANCER. VOL. 4. ISSUE 4. P. 296-307 | 99 | 84% | 397 |
9 | RABIK, CA , NJOKU, MC , DOLAN, ME , (2006) INACTIVATION OF O-6-ALKYLGUANINE DNA ALKYLTRANSFERASE AS A MEANS TO ENHANCE CHEMOTHERAPY.CANCER TREATMENT REVIEWS. VOL. 32. ISSUE 4. P. 261-276 | 124 | 83% | 56 |
10 | KAINA, B , CHRISTMANN, M , NAUMANN, S , ROOS, WP , (2007) MGMT: KEY NODE IN THE BATTLE AGAINST GENOTOXICITY, CARCINOGENICITY AND APOPTOSIS INDUCED BY ALKYLATING AGENTS.DNA REPAIR. VOL. 6. ISSUE 8. P. 1079 -1099 | 117 | 59% | 243 |
Classes with closest relation at Level 2 |